Core Viewpoint - The company held its 12th meeting of the 4th Supervisory Board, where several key financial proposals were approved, indicating a proactive approach to managing its financial resources and risks [1][2][3] Group 1: Supervisory Board Meeting - The meeting was convened on August 13, 2025, with all three supervisors present, ensuring compliance with relevant laws and regulations [1] - The meeting's resolutions were deemed legal and effective, reflecting proper governance practices [1] Group 2: Financial Proposals Approved - The proposal to use part of the idle self-owned funds for entrusted financial management was approved unanimously, indicating a strategy to optimize asset utilization [2] - The board approved the proposal for conducting foreign exchange derivative hedging transactions, aimed at mitigating adverse impacts from exchange rate fluctuations, which is beneficial for stabilizing operations [2] - The proposal to permanently supplement working capital with part of the over-raised funds was also approved, enhancing the efficiency of fund usage and reducing financial costs, aligning with regulatory requirements [2][3]

Group 1 - The company plans to use part of the excess raised funds, amounting to RMB 12,300.00 million, to permanently supplement its working capital, which accounts for 29.90% of the total excess funds raised [5][7][8] - The total amount of excess funds raised by the company is RMB 41,134.18 million, with a remaining balance of RMB 15,270.51 million as of June 30, 2025 [8] - The company has committed to not exceeding 30% of the total excess funds for permanent working capital supplementation within the last 12 months [8] Group 2 - The company has received approval from its board of directors and supervisory board for the use of excess funds, which will be submitted for shareholder meeting approval [7][9] - The use of excess funds is aimed at meeting the company's working capital needs, improving the efficiency of fund utilization, and reducing financial costs [8][9] - The company assures that there will be no change in the purpose of the raised funds and that it will not affect the normal progress of the investment projects [8][9]

Summary of Key Points Core Viewpoint - The company plans to use part of the excess raised funds, amounting to RMB 46,700,000, to permanently supplement its working capital, which aligns with its business development needs and aims to enhance profitability while safeguarding the interests of all shareholders [1][4][6]. Group 1: Fundraising Overview - The company successfully completed its initial public offering (IPO) of 329,849,630 shares at a price of RMB 9.87 per share, raising a total of RMB 3,255,615,848.10, with all funds received and verified by an accounting firm [1][2]. - The net amount raised after deducting issuance costs was RMB 306,781,460, with excess funds totaling RMB 191,781,460 [2][5]. Group 2: Use of Excess Funds - The company intends to use 24.35% of the excess funds (RMB 46,700,000) for permanent working capital, ensuring that this does not affect the funding needs of the investment projects [4][5]. - The company has committed that the total amount used for permanent working capital or repaying bank loans will not exceed 30% of the total excess funds within any twelve-month period [4][5]. Group 3: Approval Process - The decision to use excess funds was approved by the company's board of directors and supervisory board, and it will be submitted for shareholder approval [5][6]. - The supervisory board confirmed that the decision complies with relevant regulations and does not harm the interests of shareholders, particularly minority shareholders [5][6]. Group 4: Regulatory Compliance - The use of excess funds adheres to the regulations set forth by the China Securities Regulatory Commission and the Shanghai Stock Exchange regarding the management and use of raised funds [4][6].

Core Points - The company successfully completed its initial public offering (IPO) of 32,984,963 shares at a price of 9.87 RMB per share, raising a total of approximately 3.26 billion RMB, with a net amount of about 3.07 billion RMB after deducting issuance costs [1][2][3] - The company plans to use part of the excess raised funds, totaling 46.7 million RMB, to permanently supplement its working capital, which represents 24.35% of the total excess funds of 191.78 million RMB [3][5] - The decision to use excess funds for working capital was approved by the board and supervisory committee, and it will be submitted for shareholder approval [5][6] Fund Management - The company has established a special account for the management of raised funds, ensuring that the funds are used specifically for their intended purposes [2] - The total investment amount for the projects funded by the raised capital is approximately 354.98 million RMB, with 225 million RMB planned to be funded from the raised capital [2] Regulatory Compliance - The company commits that the cumulative use of excess funds for working capital or repaying bank loans will not exceed 30% of the total excess funds within any twelve-month period [4] - The use of excess funds complies with the relevant regulations set forth by the China Securities Regulatory Commission and the Shanghai Stock Exchange [4][5]

Core Viewpoint - The company held its third board meeting on August 3, 2025, where it approved several resolutions regarding amendments to its articles of association and the use of idle funds for cash management [1][2][3]. Group 1: Board Meeting Details - The board meeting was conducted via email, with all five directors present, and was chaired by Chairman Guo Jian [1]. - The meeting complied with relevant laws and regulations, including the Company Law of the People's Republic of China [1]. Group 2: Resolutions Passed - The board approved amendments to the company's articles of association in accordance with the new Company Law and other regulatory requirements [2][3]. - The board proposed to authorize the management to handle necessary business registration and filing procedures related to the amendments [1][2]. Group 3: Financial Management - The company plans to use up to RMB 400 million of idle raised funds and RMB 1.6 billion of idle self-owned funds for cash management, valid for 12 months from the approval date [3][4]. - The board also approved the permanent replenishment of working capital using RMB 162.416 million of remaining raised funds, ensuring that this does not affect the company's operational needs [4][5]. Group 4: Upcoming Shareholder Meeting - The company intends to hold its first extraordinary general meeting of 2025 on August 25, 2025, to further discuss the approved resolutions [5].

Core Viewpoint - The company has approved the use of remaining raised funds to permanently supplement its working capital, amounting to RMB 162.42 million, after a period of twelve months since the last use of excess funds [1][9]. Fundraising Overview - The company raised a total of RMB 1,890.12 million through the issuance of 57 million shares at RMB 33.16 per share, with a net amount of RMB 1,732.68 million after deducting related issuance costs [1][2]. - The excess funds raised amounted to RMB 1,132.12 million [2]. Investment Project Details - The total planned investment for the projects was RMB 600.56 million, with an actual investment of RMB 325.82 million [3]. Use of Excess Funds - The company has previously used excess funds on three occasions, each time not exceeding 30% of the total excess funds, specifically RMB 339.64 million on each occasion [4][5][6]. - The current plan to use RMB 162.42 million for working capital will not affect the funding needs of the investment projects [7][8]. Necessity and Commitment - The decision to use the remaining excess funds aims to enhance the efficiency of fund utilization, reduce financial costs, and support business operations [8][9]. - The company commits to not engage in high-risk investments or provide financial assistance to entities outside of its controlling subsidiaries within twelve months after the fund supplementation [7][9]. Approval Process - The board of directors approved the use of the remaining excess funds on August 8, 2025, and the matter will be submitted for shareholder approval [9][10].

Core Viewpoint - The company intends to use remaining raised funds to permanently supplement its working capital, which is expected to enhance the efficiency of fund utilization and reduce financial costs [1][4][6]. Fundraising Overview - The company raised a total of RMB 1,890,120,000.00 through the issuance of 57 million shares at RMB 33.16 per share, with a net amount of RMB 1,732,678,854.04 after deducting related issuance costs [1][2]. - The total amount of over-raised funds is RMB 1,132,121,954.04 [2]. Use of Over-raised Funds - The company has approved the use of RMB 339,636,000.00 from over-raised funds to permanently supplement working capital, which does not exceed 30% of the total over-raised funds [3][5][6]. - This decision was made in meetings held on November 15, 2021, October 26, 2022, and October 24, 2023, with the respective shareholder meetings following [3][4][5]. Plan for Using Remaining Over-raised Funds - The company plans to use RMB 16,241.60 million of the remaining over-raised funds for permanent working capital, ensuring that it does not affect the funding needs of investment projects [5][6]. - The company commits to not engaging in high-risk investments or providing financial assistance to entities outside of its controlling subsidiaries within 12 months after the fund supplementation [5][6]. Board and Sponsor Opinions - The board of directors has agreed to the use of remaining over-raised funds for working capital, subject to shareholder approval [7]. - The sponsor institution has confirmed that the use of these funds will improve fund utilization efficiency and will not harm shareholder interests, complying with relevant regulations [7].

Group 1 - The company Baoland announced that it will hold its first extraordinary general meeting of shareholders in 2025 on August 25, 2025 [1] - The agenda for the meeting includes the proposal to use remaining raised funds to permanently supplement working capital among other proposals [1]

一、募集资金的情况 经中国证券监督管理委员会《关于同意杭州百诚医药科技股份有限公司首次 公开发行股票注册的批复》（证监许可[2021]3566 号）核准，公司首次公开发行 人民币普通股（A 股）股票 27,041,667 股,每股面值 1 元，每股发行价格为人民 币 79.60 元，募集资金总额为人民币 2,152,516,693.20 元，扣除本次发行费用人 民币 289,086,604.79 元后，实际募集资金净额为人民币 1,863,430,088.41 元。募 集资金已于 2021 年 12 月 15 日划至公司指定账户。 经天健会计师事务所（特殊普通合伙）审验并出具"天健验[2021]738 号" 《验资报告》。公司已开设了募集资金专项账户，对募集资金采取了专户存储， 并与开户银行、保荐机构签订了《募集资金三方监管协议》。 国金证券股份有限公司 关于杭州百诚医药科技股份有限公司 部分超募资金永久补充流动资金的核查意见 国金证券股份有限公司（以下简称"保荐机构"）为杭州百诚医药科技股份 有限公司（以下简称"百诚医药"或"公司"）首次公开发行股票并在创业板上 市的保荐机构，根据《证券发行上市保荐业务管理 ...

Group 1 - The company held its 9th meeting of the 2nd board of directors, with all 5 directors present, and the meeting was deemed legally valid [1] - The board approved the revision of the company's articles of association and governance-related systems in accordance with relevant laws and regulations [1][3] - The board's resolutions received unanimous support with 5 votes in favor, and no votes against or abstentions [2] Group 2 - The company plans to use up to RMB 200 million of idle raised funds for cash management, with a rolling usage period of 12 months from the board's approval date [4][5] - The board also approved the permanent replenishment of working capital using RMB 49 million of excess raised funds, pending approval at the upcoming shareholder meeting [4][5] - The company aims to enhance the efficiency of idle self-owned funds by using up to RMB 200 million for purchasing safe and liquid financial products [5] Group 3 - The company will hold its first extraordinary general meeting of 2025 on August 18, 2025, at 14:30 in the company meeting room [5]